Relationship Between Cerebrospinal Fluid Norepinephrine and Blood Pressure in Neurologic Patients

References

• Scriabine A., Clineschmidt B. V., Sweet C. V. “Central Noradrenergic Control of Blood Pressure,”. Ann. Rev. Pharm. Tox. 1976; 16: 113
   PubMed Web of Science ®Google Scholar
• Chalmers J. P., Reid J. L. “Participation of Central Noradrenergic Neurons in Arterial Baroreceptor Reflexes in the Rabbit,”. Circ. Res. 1972; 31: 789
   PubMed Web of Science ®Google Scholar
• Reid J. L., Zivin J. A., Kopin I. J. “Central and Peripheral Adrenergic Mechanisms in the Development of Deoxycorticosterone-saline Hypertension in Rats,”. Circ. Res. 1975; 37: 569
   PubMed Web of Science ®Google Scholar
• Chalmers J. P., Dollery C. T., Lewis P. J., Reid J. L. “The Importance of Central Adrenergic Neurons in Renal Hypertension in Rabbits,”. J. Physiology 1974; 238: 403
   PubMed Web of Science ®Google Scholar
• Versteeg D. H.G., Palkovits M., Van der Gugten J., Henk L., Wijnen J. M., Smeets G. W.M., de Jong W. “Catecholamine Content of Individual Brain Regions of Spontaneously Hypertensive Rats (SH-rats),”. Brain Res. 1976; 112: 429
   PubMed Web of Science ®Google Scholar
• Haeusler G., Gerold M., Thoenen T. “Cardiovascular Effects of 6-hydroxydopamine Injected into a Lateral Brain Ventricle of the Rat,”. Naunyn Schmiedebergs Arch. Pharmacol. 1972; 274: 211
   PubMed Web of Science ®Google Scholar
• Doba N., Reis D. J. “Role of Central and Peripheral Adrenergic Mechanisms in Neurogenic Hypertension Produced by Brainstem Lesion in Rats,”. Circ. Res. 1974; 34: 293
   PubMed Web of Science ®Google Scholar
• Saran R. K., Sahuja R. C., Gupta N. N., Hasan M., Bhargava K. P., Shanker K., Kishor K. “3-Methoxy-4-Hydroxyphenylglycol in Cerebrospinal Fluid and Vanillylmandelic Acid in Urine of Humans with Hypertension,”. Science 1978; 200: 317
   PubMed Web of Science ®Google Scholar
• Murray S., Jones D. H., Davies D. S., Dollery C. T., Reid J. L. “Free and Total 3-Methoxy-4-Hydroxyphenylethylene Glycol in Human Cerebrospinal Fluid: Relationship to Blood Pressure in Hypertensives and Patients with Neuropsychiatric Disease,”. Clin. Chim. Acta 1977; 79: 63
   PubMed Web of Science ®Google Scholar
• Ziegler M. G., Lake C. R., Kopin I. J. “Norepinephrine in Cerebrospinal Fluid,”. Brain Res. 1976; 108: 436
   PubMed Web of Science ®Google Scholar
• Ziegler M. G., Lake C. R., Wood J. H., Ebert M. H. “Circadian Rhythm in Cerebrospinal Fluid Noradrenaline of Man and Monkey,”. Nature 1976; 264: 656
   PubMed Web of Science ®Google Scholar
• Ziegler M. G., Wood J. H., Lake C. R., Kopin I. J. “Norepinephrine and 3-Methoxy-4-Hydroxypenylglycol Gradients in Human Cerebrospinal Fluid,”. Am. J. Psychiatry 1977; 134(5)565
   PubMed Web of Science ®Google Scholar
• Tourtelotte W. W., Haerer A. F., Heller G. L., Somers J. E. Post-lumbar Puncture Headaches. Charles C. Thomas Publ., Springfield 1964
   Google Scholar
• Lake C. R., Ziegler M. G., Kopin I. J. “Use of Plasma Norepinephrine for Evaluation of Sympathetic Neuronal Function in Man,”. Life Science 1976; 18: 1315
   PubMed Web of Science ®Google Scholar
• Engleman K., Portnoy B., Sjoerdsma A. “Plasma Catecholamine Concentrations in Patients with Hypertension,”. Circ. Res. 1970; 27(Suppl. 1)I-141
   PubMedGoogle Scholar
• DeQuattro V., Chan S. “Raised Plasma-catecholamines in Some Patients with Primary Hypertension,”. Lancet 1972; 1: 806
   PubMed Web of Science ®Google Scholar
• Geffen L. B., Rush R. A., Louis W. J., et al. “Plasma Dopamine-β-hydroxylase and Noradrenaline Amounts in Essential Hypertension,”. Clin. Sci. (Oxf) 1973; 44: 617
   PubMed Web of Science ®Google Scholar
• Louis W. J., Doyle A. E., Anavekar S. “Plasma Norepinephrine Levels in Essential Hypertension,”. New Engl. J. Med. 1973; 288: 599
   PubMed Web of Science ®Google Scholar
• DeQuattro V., Miura Y., Lurvey A., et al. “Increased Plasma Catecholamine Concentrations and Vas Deferens Norepinephrine Biosynthesis in Men with Elevated Blood Pressure,”. Cir. Res. 1975; 36: 118
   PubMed Web of Science ®Google Scholar
• De Champlain J., Farley L., Cousineau D., et al. “Circulating Catecholamine Levels in Human and Experimental Hypertension,”. Circ. Res. 1976; 38: 109
   PubMed Web of Science ®Google Scholar
• Lake C. R., Ziegler M. G., Coleman M. D., Kopin I. J. “Age-adjusted Norepinephrine Levels are Similar in Normotensive and Hypertensive Subjects,”. New Engl. J. Med. 1977; 296: 208
   PubMed Web of Science ®Google Scholar
• Franco-Morselli R., Elghozi J. L., Joly E., Di Giuilio S., Meyer P. “Increased Plasma Adrenaline Concentrations in Benign Essential Hypertension,”. Br. Med. J. 1977; 2: 1251
   PubMed Web of Science ®Google Scholar
• Christensen M. S., Christensen N. J. “Plasma Catecholamines in Hypertension,”. Scand. J. Clin. Lab. Invest. 1972; 30: 169
   PubMed Web of Science ®Google Scholar
• Pedersen E. B., Christensen N. J. “Catecholamines in Plasma and Urine in Patients with Essential Hypertension Determined by Double-isotope Derivative Technique,”. Acta Med. Scand. 1975; 198: 373
   PubMed Web of Science ®Google Scholar
• Lake C. R., Ziegler M. G. “Effect of Acute Volume Alterations on Norepinephrine and Dopamine-β-hydroxylase in Normotensive and Hypertensive Subjects,”. Circulation 1978; 57(4)774
   PubMed Web of Science ®Google Scholar
• Ziegler M. G., Lake C. R., Kopin I. J. “Plasma Noradrenaline Increases with Age,”. Nature 1976; 261: 333
   PubMed Web of Science ®Google Scholar
• Sever P. S., Osikowska B., Birch M., Tunbridge R. D.G. “Plasma Noradrenaline in Essential Hypertension,”. Lancet 1977; 1: 1078
   PubMed Web of Science ®Google Scholar
• Fitz Gerald G. A., Hossmann V., Hamilton C. A., Reid J. L., Davies D. S., Dollery C. T. “Interindividual Variation in Kinetics of Infused Epinephrine,”. Clin. Pharmacol. Therap. 1979; 26(6)669
   PubMed Web of Science ®Google Scholar
• Kolinger W., Walland A. “Evidence for a Central Activation of a Vagal Cardiodepressor Reflex by Clonidine,”. Eur. J. Pharm. 1972; 19: 203
   PubMed Web of Science ®Google Scholar
• Shoulson I., Ziegler M. G., Lake C. R. “Huntington's Disease (HD): Determination of Plasma Norepinephrine (NE) and Dopamine-beta-hydroxylase (DBH),”. Neuroscience Abstracts 1976
   Google Scholar
• Teychenne P. F., Lake C. R., Ziegler M. G., Plotkin C., Wood J. H., Calne D. B. “Central and Peripheral Deficiency of Norepinephrine in Parkinson's Disease and the Effects of L-dopa Therapy,”. Neuroscience Abstracts 1977
   Google Scholar
• Eide I., Kolloch R., de Quattro V., Miano L., Dugger R., Van der Meulen J. “Raised Cerebrospinal Fluid Norepinephrine in Some Patients with Primary Hypertension,”. Hypertension 1979; 1: 255
   PubMed Web of Science ®Google Scholar